Patent details

Basic Information

Publication number:

EP3044222

PCT Application Number:

US2014054888

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147806632

PCT Publication Number:

WO2015038571

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ATRASENTAN MANDELATE SALTS FOR THE TREATMENT OF KIDNEY DISEASES

French Title of Invention:

SELS MANDÉLATE D'ATRASENTANE POUR LE TRAITEMENT DE NÉPHROPATHIES

German Title of Invention:

ATRASENTAN-MANDELAT-SALZE ZUR BEHANDLUNG VON NIERENERKRANKUNGEN

SPC Number:

Dates

Filing date:

10/09/2014

Grant date:

05/07/2017

EP Publication Date:

20/07/2016

PCT Publication Date:

19/03/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/07/2017

EP B1 Publication Date:

05/07/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

10/09/2017

Expiration date:

10/09/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/07/2017

 

 

Name:

Abbvie Inc.

Address:

1 North Waukegan Road, North Chicago, IL 60064, United States (US)

Inventor

1

Name:

GONG, Yuchuan

Address:

United States (US)

2

Name:

ZHANG, Geoff, G.

Address:

United States (US)

Priority

1

Priority Number:

201361877101 P

Priority Date:

12/09/2013

Priority Country:

United States (US)

2

Priority Number:

201314133297

Priority Date:

18/12/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/4025; A61P 7/12; C07D 405/04;

Publication

European Patent Bulletin

Issue number:

201727

Publication date:

05/07/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
30/01/2018	Outgoing Correspondence	1